Other NPC therapeutic vaccination approaches include cancer stem cell lysate [89], peptide cancer vaccines containing amino acid residues 340–349 or 419–427 of the EBV LMP2 protein (LMP-2:340–349, LMP-2:419–427) [89], and LMP1 plasmid DNA [90]. Here, PSMB9 is linked to nasopharyngeal carcinoma.